{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:52:52Z","timestamp":1782895972139,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.gastro.2005.08.003","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T11:21:09Z","timestamp":1129634469000},"page":"1171-1178","source":"Crossref","is-referenced-by-count":118,"title":["National Adherence to Evidence-Based Guidelines for the Prescription of Nonsteroidal Anti-Inflammatory Drugs"],"prefix":"10.1053","volume":"129","author":[{"given":"Neena S.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B.","family":"El\u2013Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2005.08.003_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.08.003_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2005.08.003_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation","volume":"160","author":"Hernandez-Diaz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00045391-200401000-00007","article-title":"Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding","volume":"11","author":"Tarone","year":"2004","journal-title":"Am J Ther"},{"key":"10.1053\/j.gastro.2005.08.003_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons","volume":"114","author":"Griffin","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF02599040","article-title":"Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs","volume":"11","author":"Smalley","year":"1996","journal-title":"J Gen Intern Med"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2005.08.003_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0016-5085(89)80061-7","article-title":"Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use","volume":"96","author":"Fries","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.08.003_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/00365529509093304","article-title":"Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates","volume":"30","author":"Hallas","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.08.003_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-109-5-359","article-title":"Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons","volume":"109","author":"Griffin","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0016-5085(03)00900-4","article-title":"Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs","volume":"125","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.08.003_bib13","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 update","volume":"43","year":"2000","journal-title":"Arthritis Rheum 2000"},{"key":"10.1053\/j.gastro.2005.08.003_bib14","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1572-0241.1998.00588.x","article-title":"A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Lanza","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.08.003_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00010","article-title":"Quality indicators for the management of osteoarthritis in vulnerable elders","volume":"135","author":"MacLean","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0889-8553(05)70253-3","article-title":"The risks and costs of upper gastrointestinal disease attributable to NSAIDs","volume":"25","author":"Smalley","year":"1996","journal-title":"Gastroenterol Clin North Am"},{"issue":"Suppl","key":"10.1053\/j.gastro.2005.08.003_bib18","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0885-3924(02)00372-X","article-title":"Update of ACR guidelines for osteoarthritis","volume":"23","author":"Schnitzer","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1053\/j.gastro.2005.08.003_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.08.003_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib21","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib22","first-page":"385","article-title":"Defining inappropriate practices in prescribing for elderly people","volume":"156","author":"McLeod","year":"1997","journal-title":"CMAJ"},{"key":"10.1053\/j.gastro.2005.08.003_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00004","article-title":"ACOVE quality indicators","volume":"135","author":"Shekelle","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib24","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/art.10425","article-title":"Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs","volume":"46","author":"Smalley","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2005.08.003_bib25","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0149-2918(01)80151-X","article-title":"Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors","volume":"23","author":"Schnitzer","year":"2001","journal-title":"Clin Ther"},{"key":"10.1053\/j.gastro.2005.08.003_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.254.10.1330","article-title":"Physician and coding errors in patient records","volume":"254","author":"Lloyd","year":"1985","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2005.08.003_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/1047-2797(95)00126-3","article-title":"Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration","volume":"6","author":"Page","year":"1996","journal-title":"Ann Epidemiol"},{"key":"10.1053\/j.gastro.2005.08.003_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.aje.a115470","article-title":"National sources of vital status information","volume":"131","author":"Boyle","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2005.08.003_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/milmed\/160.7.351","article-title":"Ascertainment of mortality in the U.S veteran population","volume":"160","author":"Page","year":"1995","journal-title":"Mil Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib30","series-title":"Use of cyclooxygenase (COX) 2 inhibitors celecoxib (Celebrex) or rofecoxib (Vioxx) in veterans","year":"2001"},{"issue":"Suppl","key":"10.1053\/j.gastro.2005.08.003_bib31","first-page":"S75","article-title":"GI score","volume":"41","author":"Singh","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2005.08.003_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2004.01935.x","article-title":"Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications\u2014review and recommendations based on risk assessment","volume":"19","author":"Chan","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2005.08.003_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2005.08.003_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2005.08.003_bib35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1345\/aph.1E052","article-title":"Nonsteroidal antiinflammatory drug use among patients with GI bleeding","volume":"38","author":"Dominick","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.gastro.2005.08.003_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-140-9-200405040-00011","article-title":"The quality of pharmacologic care for vulnerable older patients","volume":"140","author":"Higashi","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjmed.2003.08.025","article-title":"Determinants of selective cyclooxygenase-2 inhibitor prescribing","volume":"115","author":"Solomon","year":"2003","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2005.08.003_bib38","first-page":"iii23","article-title":"Underutilization of preventive strategies in patients receiving NSAIDs","volume":"42","author":"Sturkenboom","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2005.08.003_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archinte.164.11.1243","article-title":"Over-the-counter pain reliever and aspirin use with a sample of long-term cyclooxygenase 2 users","volume":"164","author":"Cox","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2005.08.003_bib40","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMsa042770","article-title":"Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors","volume":"351","author":"Fischer","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.gastro.2005.08.003_bib41","first-page":"CD003685","article-title":"Rofecoxib for the treatment of rheumatoid arthritis","author":"Garner","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2005.08.003_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2005.08.003_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505015787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505015787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T10:11:06Z","timestamp":1554113466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508505015787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0016508505015787"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2005.08.003","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}